These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19965927)

  • 1. Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women.
    Yin MT; McMahon DJ; Ferris DC; Zhang CA; Shu A; Staron R; Colon I; Laurence J; Dobkin JF; Hammer SM; Shane E
    J Clin Endocrinol Metab; 2010 Feb; 95(2):620-9. PubMed ID: 19965927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study.
    Yin MT; Zhang CA; McMahon DJ; Ferris DC; Irani D; Colon I; Cremers S; Shane E
    J Clin Endocrinol Metab; 2012 Feb; 97(2):554-62. PubMed ID: 22090266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated with Bone Mineral Density and Bone Resorption Markers in Postmenopausal HIV-Infected Women on Antiretroviral Therapy: A Prospective Cohort Study.
    Ellis C; Kruger HS; Viljoen M; Dave JA; Kruger MC
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34207469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal analysis of bone density in human immunodeficiency virus-infected women.
    Dolan SE; Kanter JR; Grinspoon S
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2938-45. PubMed ID: 16735489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women.
    Hoeg A; Gogakos A; Murphy E; Mueller S; Köhrle J; Reid DM; Glüer CC; Felsenberg D; Roux C; Eastell R; Schomburg L; Williams GR
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4061-70. PubMed ID: 22904175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral-naïve HIV-infected patients had lower bone formation markers than HIV-uninfected adults.
    Wattanachanya L; Jantrapakde J; Avihingsanon A; Ramautarsing R; Kerr S; Trachunthong D; Pussadee K; Teeratakulpisarn N; Jadwattanakul T; Chaiwatanarat T; Buranasupkajorn P; Phanuphak N; Sunthornyothin S; Phanuphak P;
    AIDS Care; 2020 Aug; 32(8):984-993. PubMed ID: 31137948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between the metabolic syndrome and its components and bone status in postmenopausal women.
    Fodor D; Vesa S; Albu A; Simon S; Craciun A; Muntean L
    Acta Physiol Hung; 2014 Jun; 101(2):216-27. PubMed ID: 24901081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
    Bone HG; Bolognese MA; Yuen CK; Kendler DL; Wang H; Liu Y; San Martin J
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2149-57. PubMed ID: 18381571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss.
    Sharma A; Cohen HW; Freeman R; Santoro N; Schoenbaum EE
    Maturitas; 2011 Nov; 70(3):295-301. PubMed ID: 21944566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between a functional interleukin-6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: the OFELY study.
    Garnero P; Borel O; Sornay-Rendu E; Duboeuf F; Jeffery R; Woo P; Delmas PD
    Bone; 2002 Jul; 31(1):43-50. PubMed ID: 12110411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study.
    Garnero P; Munoz F; Sornay-Rendu E; Delmas PD
    Bone; 2007 Mar; 40(3):716-22. PubMed ID: 17112798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women.
    Filip R; Raszewski G
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):214-20. PubMed ID: 18547340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.
    Rosen CJ; Chesnut CH; Mallinak NJ
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1904-10. PubMed ID: 9177404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between inflammatory biomarkers and bone mineral density in a community-based cohort of men and women.
    Sponholtz TR; Zhang X; Fontes JD; Meigs JB; Cupples LA; Kiel DP; Hannan MT; McLean RR
    Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1233-40. PubMed ID: 24375982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Prasitsuebsai W; Sophonphan J; Sohn AH; Ananworanich J; Puthanakit T;
    HIV Med; 2017 Apr; 18(4):235-244. PubMed ID: 27477214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Carr A; Grund B; Neuhaus J; Schwartz A; Bernardino JI; White D; Badel-Faesen S; Avihingsanon A; Ensrud K; Hoy J;
    HIV Med; 2015 Apr; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
    J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calciotropic Hormones and the Prevalence of Vertebral Fractures in Chinese Postmenopausal Women with Vitamin D Insufficiency: Peking Vertebral Fracture Study.
    Jiajue R; Jiang Y; Qi X; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
    Calcif Tissue Int; 2019 Jun; 104(6):622-630. PubMed ID: 30737534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.